U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    PTPN5 protein tyrosine phosphatase non-receptor type 5 [ Homo sapiens (human) ]

    Gene ID: 84867, updated on 17-Jun-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Tyrosine phosphatase STEP61 in human dementia and in animal models with amyloid and tau pathology.

    Tyrosine phosphatase STEP(61) in human dementia and in animal models with amyloid and tau pathology.
    Taylor D, Kneynsberg A, van Roijen M, Götz J., Free PMC Article

    01/21/2023
    Inhibition of striatal-enriched protein tyrosine phosphatase (STEP) activity reverses behavioral deficits in a rodent model of autism.

    Inhibition of striatal-enriched protein tyrosine phosphatase (STEP) activity reverses behavioral deficits in a rodent model of autism.
    Chatterjee M, Singh P, Xu J, Lombroso PJ, Kurup PK., Free PMC Article

    10/9/2021
    PTPN5 promotes follicle-stimulating hormone secretion through regulating intracellular calcium homeostasis.

    PTPN5 promotes follicle-stimulating hormone secretion through regulating intracellular calcium homeostasis.
    Wang H, Bu S, Tang J, Li Y, Liu C, Dong J.

    07/31/2021
    that STEP61 is the molecular brake that is lost following KCC2-dependent disinhibition and that the decrease in STEP61 activity drives the potentiation of excitatory GluN2B NMDAR responses in rodent and human models of pathological pain

    Loss of STEP61 couples disinhibition to N-methyl-d-aspartate receptor potentiation in rodent and human spinal pain processing.
    Dedek A, Xu J, Kandegedara CM, Lorenzo LÉ, Godin AG, De Koninck Y, Lombroso PJ, Tsai EC, Hildebrand ME., Free PMC Article

    03/14/2020
    validated the functional importance of an identified interaction network by characterizing a distinct novel interaction between PTPN5 and Mob1a.

    A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.
    Kumar P, Munnangi P, Chowdary KR, Shah VJ, Shinde SR, Kolli NR, Halehalli RR, Nagarajaram HA, Maddika S., Free PMC Article

    05/19/2018
    This current study demonstrated that spinal STEP61 regulated LTP of C fiber-evoked field potentials, one of the extensively studied cellular models of central sensitization.

    Striatal-enriched phosphatase 61 inhibited the nociceptive plasticity in spinal cord dorsal horn of rats.
    Suo ZW, Liu JP, Xue M, Yang YH, Yang X, Xie J, Hu XD.

    03/10/2018
    a dual role for PSD-95 in stabilizing synaptic NMDARs by binding directly to GluN2B but also by promoting synaptic exclusion and degradation of the negative regulator STEP61.

    PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61.
    Won S, Incontro S, Nicoll RA, Roche KW., Free PMC Article

    02/3/2018
    STEP is involved in the mechanism of depressive disorders and it is a promising molecular target for atypical antidepressant drugs of new generation. (Review)

    Striatal-enriched Tyrosine Protein Phosphatase (STEP) in the Mechanisms of Depressive Disorders.
    Kulikova E, Kulikov A.

    11/11/2017
    Data suggest that PP5/PTPN5 is overexpressed in liver samples from patients with hepatocellular carcinoma (HCC); overexpression of PP5/PTPN5 appears to correlate with tumor burden/stage. Inhibition of PP5/PTPN5 suppresses proliferation and promotes apoptosis of HCC cells; inhibition of PP5/PTPN5 involves activation of AMPK.

    Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
    Chen YL, Hung MH, Chu PY, Chao TI, Tsai MH, Chen LJ, Hsiao YJ, Shih CT, Hsieh FS, Chen KF.

    07/29/2017
    A rare missense variant in the PTPN5 gene (rs56234898; minor allele frequency 1.5%) was significantly associated with decreased severity of Post-Burn Hypertrophic Scarring(P = 1.3x10-6).

    Missense Variant in MAPK Inactivator PTPN5 Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring.
    Sood RF, Arbabi S, Honari S, Gibran NS., Free PMC Article

    07/30/2016
    STEP levels are unchanged in pre-frontal cortex and associative striatum in post-mortem human brain samples from subjects with schizophrenia, bipolar disorder and major depressive disorder

    STEP levels are unchanged in pre-frontal cortex and associative striatum in post-mortem human brain samples from subjects with schizophrenia, bipolar disorder and major depressive disorder.
    Lanz TA, Joshi JJ, Reinhart V, Johnson K, Grantham LE 2nd, Volfson D., Free PMC Article

    02/20/2016
    Article focuses on the most recent findings on STEP, discuss how STEP expression and activity are maintained during normal cognitive function, and how disruptions in STEP activity contribute to a number of illnesses. [Review]

    Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders.
    Karasawa T, Lombroso PJ., Free PMC Article

    10/31/2015
    Decreased STEP protein activation in corpus striatum contributes to early enhanced apoptotic signaling in YAC model transgenic mice.

    Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.
    Gladding CM, Fan J, Zhang LY, Wang L, Xu J, Li EH, Lombroso PJ, Raymond LA., Free PMC Article

    08/30/2014
    This experiments demonstrated that deletion of STEP can enhance experience-induced neuroplasticity and memory formation

    The tyrosine phosphatase STEP constrains amygdala-dependent memory formation and neuroplasticity.
    Olausson P, Venkitaramani DV, Moran TD, Salter MW, Taylor JR, Lombroso PJ., Free PMC Article

    04/20/2013
    The results imply a model in which PTPN5 may play a role in normal cognitive functioning and contribute to aspects of the neuropathology of schizophrenia.

    Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition.
    Pelov I, Teltsh O, Greenbaum L, Rigbi A, Kanyas-Sarner K, Lerer B, Lombroso P, Kohn Y., Free PMC Article

    11/17/2012
    This study identified a novel role for PTPN5 in mediating the development of stress-related cognitive and morphological changes.

    A critical role for protein tyrosine phosphatase nonreceptor type 5 in determining individual susceptibility to develop stress-related cognitive and morphological changes.
    Yang CH, Huang CC, Hsu KS., Free PMC Article

    08/11/2012
    STEP(61kDa) is required for Abeta transgene-mediated internalization of GluA1/GluA2 glutamate receptors in a transgenic mousemodel.

    Reduced levels of the tyrosine phosphatase STEP block β amyloid-mediated GluA1/GluA2 receptor internalization.
    Zhang Y, Kurup P, Xu J, Anderson GM, Greengard P, Nairn AC, Lombroso PJ., Free PMC Article

    12/3/2011
    STEP contributes to aspects of the pathophysiology in Alzheimer's disease; loss of GluN1/GluN2B subunits from neuronal membranes and Abeta-mediated NMDAR internalization are discussed

    The role of STEP in Alzheimer's disease.
    Kurup P, Zhang Y, Venkitaramani DV, Xu J, Lombroso PJ., Free PMC Article

    05/14/2011
    Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)

    Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
    Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR., Free PMC Article

    06/30/2010
    findings show that STEP(61) levels are progressively increased in the prefrontal cortex of Alzheimer disease brains

    Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61.
    Kurup P, Zhang Y, Xu J, Venkitaramani DV, Haroutunian V, Greengard P, Nairn AC, Lombroso PJ., Free PMC Article

    05/31/2010
    in colorectal tumors, microsatellite repeats mutation rates are higher than the mean mutation frequency

    Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.
    Korff S, Woerner SM, Yuan YP, Bork P, von Knebel Doeberitz M, Gebert J, Korff S, Woerner SM, Yuan YP, Bork P, von Knebel Doeberitz M, Gebert J., Free PMC Articles: PMC2586028, PMC2586028

    01/21/2010
    Observational study of gene-disease association. (HuGE Navigator)

    Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.
    Korff S, Woerner SM, Yuan YP, Bork P, von Knebel Doeberitz M, Gebert J, Korff S, Woerner SM, Yuan YP, Bork P, von Knebel Doeberitz M, Gebert J., Free PMC Articles: PMC2586028, PMC2586028

    11/26/2008
    determined high-resolution structures of all of the human family members of Mitogen-Activated Protein Kinase-specific protein tyrosine phosphatases

    Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases.
    Eswaran J, von Kries JP, Marsden B, Longman E, Debreczeni JE, Ugochukwu E, Turnbull A, Lee WH, Knapp S, Barr AJ., Free PMC Article

    01/21/2010
    firstprevious page of 1 nextlast